Drug Shortage Report for ACT MEMANTINE
Report ID | 190680 |
Drug Identification Number | 02324067 |
Brand name | ACT MEMANTINE |
Common or Proper name | ACT-MEMANTINE 10MG FC TABLETS 100 |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | MEMANTINE HYDROCHLORIDE |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N06DX |
ATC description | ANTI-DEMENTIA DRUGS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-04-27 |
Estimated end date | 2023-10-31 |
Actual end date | 2023-11-20 |
Shortage status | Resolved |
Updated date | 2023-11-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v22 | 2023-11-21 | English | Compare |
v21 | 2023-11-03 | French | Compare |
v20 | 2023-11-03 | English | Compare |
v19 | 2023-10-19 | French | Compare |
v18 | 2023-10-19 | English | Compare |
v17 | 2023-10-12 | French | Compare |
v16 | 2023-10-12 | English | Compare |
v15 | 2023-10-05 | French | Compare |
v14 | 2023-10-05 | English | Compare |
v13 | 2023-10-04 | French | Compare |
v12 | 2023-10-04 | English | Compare |
v11 | 2023-08-17 | French | Compare |
v10 | 2023-08-17 | English | Compare |
v9 | 2023-08-04 | French | Compare |
v8 | 2023-08-04 | English | Compare |
v7 | 2023-07-19 | French | Compare |
v6 | 2023-07-19 | English | Compare |
v5 | 2023-07-06 | French | Compare |
v4 | 2023-07-06 | English | Compare |
v3 | 2023-04-28 | English | Compare |